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Background
Vascular mineralization is a passive end-stage process in stenosis of arteries (Schurgers et al. 
2013). Vitamin K-dependent matrix Gla protein (MGP) is known a calcium scavenger and 
may play a dominant role in vascular calcium metabolism. It is a mineral-binding extra-
cellular matrix (ECM) protein mostly expressed by vascular smooth muscle cells (VSMCs), 
osteoblasts and chondrocytes. It is generally believed as potent inhibitor of arterial calcifi-
cation (Schurgers et al. 2008). A study showed that MGP knockout (MGP−/−) mice devel-
oped blood vessel rupture and died due to arterial calcification after 2 months (Luo et al. 
1997). The MGP gene (Entrez; Gene ID: 4256) is located on the short arm of chromosome 
12 (12p12.3). dbSNP data (www.ncbi.nlm.nih.gov/snp) showed that polymorphic sites are 
widely distributed in the different regions of MGP gene and are potentially related to the 
MGP function (Farzaneh-Far et al. 2001). Furthermore, the MGP rs1800801 and rs1800802 
promoter–reporter gene constructs showed that the rs1800802 C allele consistently reduces 
promoter activity in vascular smooth muscle cells (Herrmann et al. 2000).
Although haplotype blocks are referred as variant distributions in several loci but we 
defined the haplotypes based on the distribution of polymorphisms within transcrip-
tion factor elements located separately on the MGP promoter. In previous study, we 
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predicted the high minimal allele frequency (MAF) polymorphic scores for each tran-
scription factor element and showed that the rs1800801, rs1800802 and rs1800799 
haplotypes within the MGP promoter did not relate to stenosis of coronary arteries. 
Moreover, serum MGP concentration was not associated to the genotype and haplo-
type distributions (Najafi et al. 2014). In this study, we followed our investigations and 
focused on the promoter expression power using polymorphic constructs in human 
MGP high expressed G292 osteoblast cells.
Methods
High and low frequent haplotype constructs
The haplotype constructs (TCA and CTG) were obtained by direct haplotyping with 
ARMS and RFLP–PCR methods as reported in the previous study (Najafi et al. 2014). 
At first, the amplified two-allele fragments containing the rs1800802 heterozygote were 
separated by ARMS–PCR technique at the rs1800801 position. The ARMS–PCR reac-
tions were performed in two microtubes (25 µl) containing MgCl2 (1.5 mM), Hot-start 
Taq plus DNA polymerase (1.25  U), genomic DNA (0.2  µg), Common Primer (1  µM; 
5′-AGTGGAACAACCGCCAGTCTCATTAG-3′) and Allele Specific (AS) Primers 
(1  µM; 5′-GCAGCAGTAGGGAGAGAGGCTCCTAC-3′ and 5′-GCAGCAGTAGG 
GAGAGAGGCTCCTAT-3′). The temperature cycles (n = 30) were followed after incu-
bation at 95 °C for 5 min (95 °C for 30 s, 68 °C for 50 s and 72 °C for 90 s) and a final 
extension at 72 °C for 7 min. Then, each allele was amplified with the designed forward 
and reverse primers to insert the digestible elements within constructs based on the pre-
vious PCR condition (Fig. 1).
DNA cloning
Digestion and ligation
 The haplotype constructs were digested with SspI (NEB; Cat. No. R0132L, 10 U, over-
night) and HindIII (NEB; Cat. No. R0104S, 8 U, overnight) restriction enzymes. Then, 
the fragments were evaluated on agarose gel 3.5 % (w/v). The pGL3-Basic plasmid (Pro-
mega; AC U47295) was also digested by SmaI (NEB; Cat. No. RO141L, 10 U, overnight) 
and HindIII (8 U, overnight) enzymes (Fig. 2).
Rapid DNA dephose and ligation kit (Roche; Cat. No. 11 635 379 001) was used for 
the ligation of fragments at the upstream region of reporter gene. The results were con-
firmed on agarose gel 2 % (w/v). Briefly, 1 µl (200–300 ng) of pGL3-Basic plasmid, 1 µl 
of fragment (20–50 ng), 10 µl of T4 DNA ligation buffer and 1.5 µl of T4 DNA ligase (7.5 
U) were gently mixed and incubated for 30 min at room temperature followed up to 24 h 
at 16 °C (Figs. 1, 2).
Cell culture
The human G292 osteoblast cells were harvested in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 5 % (v/v) fetal bovine serum (FBS) at 37  °C in a humidi-
fied CO2 atmosphere 5 %. The plasmid transfection was conducted by X-tremeGENE 
HP DNA transfection reagent (Roche; Cat. No. 06366244001) to introduce plasmids into 
cells essentially. They were transferred into 6-well plates (confluency; 70 %) and, were 
exposed for 4 h with 200 µl of transfection complex (2 µg of constructed plasmid and 
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6 µl X-tremeGENE). Then, the transfected cells (2 millions) were treated with phorbol 
12-myristate 13-acetate (Sigma; Cat. No. P8139) for 2 h and, were grown for 24 h.
RNA extraction and cDNA synthesis
Total RNA was isolated from the plasmid-transfected cells using HP RNA isolation 
kit (Roche; Cat. No. 11 828 665 001) as described by the manufacturer’s instructions. 
Genomic DNA was eliminated by DNase I during the extraction procedure. Briefly, the 
cells were washed three times using cold phosphate-buffered saline solution (PBS) and, 
were harvested in 400  µl of lysis-binding buffer followed by centrifugation to remove 
a  rs1800802 heterozygote 
AGTGGAACAACCGCCAGTCTCATTAG (1062bp) AG(C/T) CCTA (367bp) TGAC(T&C)GTTT(125bp)CC(G/A)ATCCTCGGAGAGAGGGATGACGACG
b  ARMS technique 
AGTGGAACAACCGCCAGTCTCATTAG (1062bp) AG(C/T) CCTA (367bp) TGAC(T&C)GTTT(125bp)CC(G/A)ATCCTCGGAGAGAGGGATGACGACG
c  ARMS Products 
1: 
AGTGGAACAACCGCCAGTCTCATTAG (1062bp) AG(C/T) CCTA (367bp) TGAC TGTTT(125bp)CCGATCCTCGGAGAGAGGGATGACGACG
2: 
AGTGGAACAACCGCCAGTCTCATTAG (1062bp) AG(C/T) CCTA (367bp) TGACCGTTT(125bp)CCAATCCTCGGAGAGAGGGATGACGACG
d  Insertion of restriction enzyme elements  
1: 
ctgggagaAATATT GGTCTAGGATTCAGCCCTA (367bp) TGAC TGTTT(125bp)CCGTAGGAGCCTCTCTAAGCTTgacgacgatg
2: 
actgggagaAATATTGGTCTAGGATTCAGTCCTA (367bp) TGAC CGTTT(125bp)CCATAGGAGCCTCTCTAAGCTTgacgacgatg
e  Construct insertion into pGL3-Basic plasmid  
ATTGGTCTAGGATTCAGTCCTA (367bp) TGAC CGTTT(125bp)CCATAGGAGCCTCTCTA
    rs1800799 2080081sr    rs1800801Common Primer Allele Specific (AS) Primer
    rs1800799 2080081sr    rs1800801
    rs1800799 2080081sr    rs1800801
    rs1800799 2080081sr    rs1800801
    rs1800799     rs1800802    rs1800801
    rs1800799     rs1800802    rs1800801
HindIII
HindIII
SspI
SspI
    rs1800799     rs1800802    rs1800801 HindIIISspI
Fig. 1 Construct preparation and plasmid insertion
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cellular debris. Then, wash buffer (400 µl) was added and centrifuged. After adding 50 µl 
of elution buffer, RNA was stored at −80 °C.
cDNA synthesis was carried out with QuantiTect Reverse Transcription kit (Qiagen; 
Cat. No. 205310) using random primers in a total volume of 20 µl. Quality of cDNA was 
tested through PCR reaction.
Real‑time qPCR technique
The luciferase expression level was measured with QuantiFast SYBER Green PCR kit 
(Qiagen; Cat. No. 204054) using specific primers (0.5  µM each). The reporter gene 
was located in the downstream of pGL3-Basic plasmid-inserted haplotype constructs 
and was not able to express in the cell model. The primers were designed by Genamics 
Expression software. Furthermore, the beta-actin (ACTB) gene was applied as endog-
enous gene (Table 1).
The temperature cycles (n = 40) for luciferase gene were followed after incubation at 
95 °C for 5 min (95 °C for 10 s, 68 °C for 15 s and 72 °C for 15 s). Also, the temperature 
cycles (n = 40) for ACTB gene were followed after incubation at 95 °C for 5 min (95 °C 
for 15 s, 67 °C for 15 s and 72 °C for 15 s). Standard curves were composed of tenfold 
dilutions and, melting curves ranged from 65 to 95 °C by steps of 0.5 °C were performed 
to evaluate non-specific products.
Fig. 2 pGL3 Basic plasmid and constructs on agarose gel. I ARMS products; the ARMS–PCR reactions were 
performed in two microtubes and the products (1624 bp) were run on the agarose gel (2 %) electrophoresis 
(Lanes A, B and Ladder). II Constructs containing three polymorphic sites were digested using restriction 
enzymes (REs) and were run on the agarose gel (3.5 %) electrophoresis (A amplified product, 568 bp, B diges-
tion with SspI, 555 bp, C digestion with SspI and HindIII, 540 bp). III pGL3 Basic plasmid was digested using 
restriction enzymes (SmaI and HindIII) and was run on the agarose gel (2 %) electrophoresis (A intact plasmid, 
B digested plasmid with REs). IV The REs-digested constructs (539 bp) were inserted and ligated into pGL3 
Basic plasmid and were compared on the agarose gel (2 %) (A construct-inserted plasmid, B intact plasmid)
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Statistical analysis
Statistical analysis was performed using statistical software package (SPSS 18, Chicago). 
Relative expression was measured and tested according to Pfaffl formula (2−CT). The 
expression levels from CTG (n = 6 wells) and from TCA (n = 6 wells) cell cultures were 
compared using Mann–Whitney U test. p Value <0.05 was considered to be significant.
Results
TCA and CTG haplotypes (rs1800799, rs1800802 and rs1800801) were successfully 
constructed by the PCR techniques. The construct and insertion results were correctly 
considered on the agarose gel. The pGL3-Basic construct-inserted plasmids were trans-
ferred into osteoblast cells and, were subjected for reporter gene expression. The results 
showed that the relative expression of reporter gene (CTG 1.5 ±  0.4; TCA 1.2 ±  0.2) 
was not significantly different (p > 0.3). The findings showed that CTG and TCA haplo-
types cannot functionality affect the expression patterns in human G292 osteoblast cells 
(Fig. 3).
Discussion
Matrix Gla protein (84  aa, 14  kDa) is a secretary protein containing five 
γ-carboxyglutamic acid (Gla) residues originally isolated from bone (Schurgers et  al. 
2013). Its expression is also reported in other tissues including kidney, lung, heart and 
cartilage. Studies have also been reported the MGP gene expression in vascular smooth 
muscle cells (VSMCs), endothelial cells (ECs) and fibroblasts (Price et al. 1976).
In vitro studies revealed that the rs1800801 A variant had an approximately 1.5-fold 
higher activity than G variant in VSMCs (Farzaneh-Far et  al. 2001). Herrmann et  al. 
Table 1 Primers used for RT-qPCR reaction
Primer Sequence Tannealing
F-luciferase 5′-CATAGCTTCTGCCAACCGAACG-3′
R-luciferase 5′-GGAAGATGGAACCGCTGGAGAG-3′ 68
F-ACTB 5′-GCGAGAAGATGACCCAGATCATG-3′
R-ACTB 5′-CGTCACCGGAGTCCATCACG-3′ 67
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Fig. 3 Relative expression level between high and low frequency haplotypes
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carried out transient transfection experiments with allele promoter–reporter gene con-
structs and DNA–protein interaction assays to investigate the functionality of promoter 
rs1800802 and rs1800801 variants. The minor rs1800802 C allele consistently conferred 
a reduced promoter activity of 20 % in rat vascular smooth muscle cells and of 50 % in 
a human fibroblast cell line whereas the other polymorphisms including rs1800801 dis-
played no evidence of in  vitro functionality (Herrmann et  al. 2000). The relationships 
were inconsistent and limited to independent roles of polymorphic sites. It was neces-
sary to show the additive effects on transcription factor elements if there is any associa-
tion between the mentioned polymorphic sites. In agreement with others (Farzaneh-Far 
et al. 2001; Crosier et al. 2009) and our previous report (Najafi et al. 2014), the popula-
tion studies showed no difference between MGP concentration and promoter polymor-
phic variants. We also didn’t find the association between serum MGP concentrations 
and two-allele haplotypes in population using direct haplotyping and prediction tools. 
We confined our study to dominant and recessive haplotypes to show whether there is 
any association between polymorphic sites and also their phenotypes using transient 
transfection experiments. Other polymorphic sites present in promoter region might 
affect the gene expression patterns, potentially present also in our constructs, which 
have not the same genetic background of the haplotypes found in the population. How-
ever, these variants are present also in the control constructs. We aimed in fact to verify 
the differences in expression patterns due to the three SNPs, to test whether they are 
functional and the responsible of the phenotypic variability observed in the population. 
Although the dominant haplotype (CTG) showed slightly a higher expression than the 
recessive haplotype (TCA), the difference was not statistically significant. These results 
supported the population and prediction studies that the allele changes within the ele-
ments could not significantly affect the functionality of the promoter.
Conclusions
We concluded that the high and low frequent polymorphic haplotypes within MGP 
promoter region have not the effect on functionality of promoter and, could not signifi-
cantly affect the phenotype.
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